Reducing Disparities in Medication Adherence in SLE

Not Applicable

Completed

Brief Summary: This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus

Recruitment & Eligibility

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Arm && Interventions

Group	Intervention	Description
Intervention arm	Behavioral Intervention	Lupus clinic providers will use Surescripts refill information to assess adherence level and address adherence barriers. We will assess the feasibility and acceptability of the intervention.

Primary Outcome Measures

Name	Time	Method
Acceptability as Measured by Provider Survey	12 weeks	Acceptability as measured by provider survey, score range 1-5, with a higher score indicating that the intervention was more acceptable.
Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence	12 weeks	Feasibility as measured by documentation of adherence assessment made by provider.

Secondary Outcome Measures

Name	Time	Method
Percentage of Adherent Participants as Determined by Medication Possession Ratio (MPR)	Baseline, 12 weeks	Medication Possession Ratio (MPR) = days with medication/total days. This will be determined by pharmacy refill data and calculated for 3 months (90 days). An MPR \> or = 80% indicates adherence.
Medication Adherence as Determined by Self Report	12 weeks

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial